LinkedIN
About
Digitizing the Sense of Touch for Healthcare
Bridging the 'Telehealth Blindspot' with Fabtive - the world's first Active Fabric for remote tactile therapy. Revolutionary software-controlled fabric technology that brings the missing sense of touch to digital healthcare.
The Challenge
The Telehealth Blindspot
Limited Senses
Current telehealth platforms rely exclusively on sight and sound, leaving touch-a critical therapeutic modality-completely offline.
Lost Impact
40% of therapy effectiveness is lost due to the absence of physical-clinical connection between clinics and patients' homes.
Missing Link
Touch remains the only human sense that hasn't been successfully integrated into digital health delivery systems.
Innovation
Fabtive Technology: The Solution
Bi-directional Clinical Loop
Our smart, soft, and washable active fabric delivers software-controlled tactile stimuli while simultaneously measuring patient responses in real-time. This creates a complete feedback loop between clinician and patient.
Fabtive enables scalable, data-driven, and personalized tactile therapy that transforms how healthcare professionals deliver remote treatment.
Scalable
Deploy therapeutic touch interventions across unlimited patient populations without geographical constraints.
Data-Driven
Real-time measurement and analysis of patient responses enables evidence-based treatment optimization.
Personalized
Software-controlled stimuli adapt to individual patient needs and therapeutic protocols dynamically.
Market Opportunity
Massive Addressable Market
$15.5B+
U.S. Market Size
Total addressable market in U.S. Behavioral Health sector with strong growth trajectory.
40%
Online Sessions
Of all therapy sessions are already conducted online but currently lack physical intervention capabilities.
60-70%
Insurance Coverage
ACA Silver and Bronze standard plans provide robust coverage for telehealth services.
The convergence of widespread telehealth adoption, substantial insurance coverage, and the critical gap in tactile therapy creates an unprecedented market opportunity for Fabtive technology.
The 2026 RTM Window: Turning Clinical Care into Scalable Revenue
Why Now? The 2026 CMS Paradigm Shift For the first time, new CMS regulations (Jan 2026) authorize reimbursement for short-cycle (2-15 days) remote therapeutic monitoring. This creates a high-margin revenue stream for clinics using Plectrum’s RTM-ready platform.
  • Immediate ROI: Hardware costs covered within 3–4 months.
  • Scalable Income: $120–$200 recurring
  • monthly revenue per patient.
  • Proven Compliance: Automated data logs for seamless billing.
Source: Figures based on CMS CY 2026 Physician Fee Schedule (PFS) National Average. Actual reimbursement rates may vary based on geographic location (GPCI adjustments), provider specialty, and individual private payer contracts.
The Scalability Edge: From Patient Care to Practice Growth
Our AI-driven platform doesn’t just improve clinical outcomes; it transforms your practice's unit economics. By automating the data collection required for RTM, Plectrum allows providers to scale their patient reach without increasing administrative overhead.
  • Compound Revenue: As your patient base grows, the RTM framework creates a predictable, high-margin recurring income.
  • Operational Efficiency: Automated documentation ensures a 95% claims approval rate, minimizing the "denial gap" typical of manual remote monitoring.
  • Future-Proofing: Partners joining today secure priority access to our next-generation Fabtive™ active fabric protocols.
Calculated based on CMS CY 2026 National Physician Fee Schedule. Actual reimbursement amounts are subject to geographic adjustment factors (GPCI) and specific payer contracts.
Sources: CMS Final Rule - CY 2026 Updates ; CMS.gov - Physician Fee Schedule ; Federal Register - Medicare Program Changes
Clinical Excellence
Validated by Leading Medical Institution
Hadassah Medical Center Accelerator
Fabtive technology was developed and refined through the prestigious Hadassah Medical Center Accelerator program, one of Israel's premier healthcare innovation hubs.
Our ongoing collaboration with Prof. Tennenbaum ensures rigorous clinical protocols and evidence-based development. Active clinical trials are underway to validate therapeutic outcomes.
Academic Partnership
Deep collaboration with leading medical researchers and practitioners ensures clinical relevance and scientific rigor.
Active Protocols
Multiple clinical validation studies currently in progress across various therapeutic applications and patient populations.
Evidence-Based
Committed to peer-reviewed publication and regulatory approval pathways for maximum market credibility.
Shape the Future of Tactile Therapeutics
Join Plectrum’s mission to bridge the "Tangibility Gap" in digital care. We are now accepting applications for our 2026 Clinical Pilot Program.
Secure your spot to experience the world’s first AI-driven haptic platform and lead the transition to objective, reimbursable sensory medicine.
or Scan the QR Code to join our journey
Our Team
Mission-Critical Expertise
IDF Unit 81 Veterans
Elite intelligence unit experience in mission-critical systems design, development, and deployment under extreme conditions.
IAI Background
Proven track record from Israel Aerospace Industries in developing cutting-edge technologies for complex operational environments.
Material Science Ph.D.
Deep academic expertise in advanced materials, sensors, and fabric engineering ensures technical innovation leadership.
Our team combines operational excellence, aerospace-grade engineering standards, and advanced scientific research to deliver breakthrough medical technology solutions. This unique combination of skills ensures both innovation and execution.
Investment Opportunity
Join Us in Revolutionizing Healthcare
Raising $1.7M Seed Round
We're seeking strategic investors to accelerate clinical validation, scale production, and capture the massive telehealth market opportunity. Your investment will fund critical clinical trials, regulatory approvals, and initial market deployment.
Partner with us to bring the missing sense of touch to digital healthcare and transform therapeutic outcomes for millions of patients worldwide.
Gabriel Lev-Har, CEO
+972-52-680-8756
gabriel@plectrum.biz
Set a 30 minutes meeting with me
©2026 by Plectrum.